Defective expression and function of the ILT2/CD85j regulatory receptor in dendritic cells from patients with systemic lupus erythematosus

Human Immunology

Volumn 74, Issue 9, 2013, Pages 1088-1096

  Monsiváis Urenda, Adriana ^a,b   Gómez Martin, Diana ^a   Santana de Anda, Karina ^a   Cruz Martínez, José ^a   Alcocer Varela, Jorge ^a   González Amaro, Roberto ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; IG LIKE TRANSCRIPT 2 RECEPTOR; LYMPHOCYTE RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY; HUMAN; IMMUNOGENETICS; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYELOID CELLS; RECEPTORS, IMMUNOLOGIC; YOUNG ADULT;

EID: 84880929445     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.05.006     Document Type: Article

References (44)

1. Steinman R., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 49:419-425.
2. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
3. Bonasio R., Scimone M.L., Schaerli P., Grabie N., Lichtman A.H., von Andrian U.H. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 2006, 7:1092-1100.
4. Ohnmacht C., Pullner A., King S.B., et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009, 206:549-559.
5. Manicassamy S., Pulendran B. Dendritic cell control of tolerogenic responses. Immunol Rev 2011, 241:206-227.
6. Cambier J.C. Inhibitory receptors abound?. Proc Natl Acad Sci U S A 1997, 94:5993-5995.
7. Brown D., Trowsdale J., Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004, 64:215-225.
8. Cosman N., Fanger N., Borges L., Kubin M., Peterson L., Hsu M.L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997, 7:273-282.
9. Sayós J., Martínez-Barriocanal A., Kitzig F., Bellón T., López-Botet M. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem Biophys Res Commun 2004, 324:640-647.
10. Saverino D., Fabbi M., Ghiotto F., et al. The CD85/LIR-1/ILT2 Inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol 2000, 165:3742-3755.
11. Colonna M., Navarro F., Bellón T., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997, 186:1809-1818.
12. Saverino D., Ghiotto F., Merlo A., et al. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J Immunol 2004, 172:5629-5637.
13. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005, 115:433-440.
14. Dietrich J., Cella M., Colonna M. Ig-like transcript 2 (ILT2)/Leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J Immunol 2001, 166:2514-2521.
15. Tenca C., Merlo A., Merck E., et al. CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. J Immunol 2005, 174:6757-6763.
16. Mills J.A. Systemic lupus erythematosus. N Engl J Med 1994, 329:1871-1879.
17. Mok C.C., Lau C.S. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003, 56:481-490.
18. Lipsky P.E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001, 2:764-766.
19. Alvarado-Sánchez B., Portales-Pérez D., Baranda L., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006, 27:110-118.
20. Kammer G.M., Perl A., Richardson B.C., Tsokos G.C. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 2002, 46:1139-1154.
21. Takeuchi T., Tsuzaka K., Abe T. Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus. Int Rev Immunol 2004, 23:273-291.
22. Liossis S.N., Ding X.Z., Dennis G.J., Tsokos G.C. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 1998, 101:1448-1457.
23. Frisoni L., McPhie L., Colonna L., et al. Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway to autoimmunity?. J Immunol 2005, 175:2692-2701.
24. Lovgren T., Eloranta L.M., Bave U., Alm G.V., Ronnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 2004, 50:1861-1872.
25. Fransen J.H., van der Vlag J., Ruben J., Adema G.J., Berden J.H., Hilbrands L.B. The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther 2010, 12:207-214.
26. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
27. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35:630-640.
28. Marazuela M., García-López M.A., Figueroa-Vega N., et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 2006, 91:3639-3646.
29. Figueroa-Vega N., Galindo-Rodríguez G., Bajaña S., et al. Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus. Scand J Immunol 2006, 64:668-676.
30. Young N.T., Waller E.C.P., Patel R., Roghanian A., Austyn J.M., Trowsdale J. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood 2008, 111:3090-3096.
31. Gregori S. Dendritic cells in networks of immunological tolerance. Tissue Antigens 2010, 77:89-99.
32. Bolland S., Ravetch J.V. Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity 2000, 13:277-285.
33. Nakamura A., Yuasa T., Ujike A., et al. Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 2000, 191:899-906.
34. Monsiváis-Urenda A., Niño-Moreno P., Abud-Mendoza C., Baranda L., López-Botet M., González-Amaro R. Analysis of expression and function of the inhibitory receptor ILT2(CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). J Autoimmun 2007, 29:97-105.
35. Scheinecker C., Zwölfer B., Köller M., Männer G., Smolen J.S. Alterations of dendritic cells in systemic lupus erythematosus. Phenotypic and functional deficiencies. Arthritis Rheum 2001, 44:856-865.
36. Blomberg S., Maija-Leena E., Magnusson M., Gunnar V.A., Rönmblom L. Expression of the markers BDCA-2 and BDCA-4 and production of Interferon-α by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003, 48:2524-2532.
37. Robak E., Smolewski P., Wozniacka A., Sysa-Jedrzejowzka A., Robak T. Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus. Mediators Inflamm 2004, 13:171-180.
38. Camporeale A., Poli V. IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?. Front Biosci 2012, 17:2306-2326.
39. Llorente L., Zou W., Levy Y., et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995, 181:839-844.
40. Won K.J., Lee H.M., Lee C.K., et al. Protein tyrosine phosphatase SHP-2 is positively involved in platelet-derived growth factor-signaling in vascular neointima formation via the reactive oxygen species-related pathway. J Pharmacol Sci 2011, 115:164-175.
41. Mamik M.K., Ghorpade A. Src homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytes. PLoS One 2012, 7:e45596.
42. Ding D., Mehta H., McCune W.J., Kaplan M.J. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 2006, 177:5878-5889.
43. Gilbert M.R., Carnathan D.G., Cogswell P.C., Lin L., Baldwin A.S., Vilen B.J. Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion. J Immunol 2007, 178:4803-4810.
44. Daca A., Czuszyńska Z., Smoleńska Z., Zdrojewski Z., Witkowski J.M., Bryl E. Two systemic lupus erythematosus (SLE) global disease activity indexes- the SLE disease activity index and the systemic lupus activity measure-demonstrate different correlations with activation of peripheral blood CD4+ T cells. Hum Immunol 2011, 72:1160-1167.